Quadrature Capital »

Zentalis Pharmaceuticals shares owned by Quadrature Capital

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Quadrature Capital from 13F filings

Historical chart of Quadrature Capital investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Quadrature Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Quadrature Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $186k 138k 1.35

More positions owned by Quadrature Capital

Advanced Micro Devices (AMD)
UnitedHealth (UNH)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Canadian Natl Ry (CNI)
Sandisk Corp (SNDK)
Asml Holding N V N Y Registry Shs (ASML)
Ge Vernova (GEV)
Tesla Motors (TSLA)
Stellantis SHS (STLA)
Netflix (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Booking Holdings (BKNG)
Agnico (AEM)
Lockheed Martin Corporation (LMT)

View all positions for Quadrature Capital

Top funds holding Zentalis Pharmaceuticals

5AM Venture Management
Renaissance Technologies
Vanguard Group
Acadian Asset Management
Citadel Advisors
Two Sigma Advisers
D. E. Shaw & Co
Opaleye Management
Two Sigma Investments
Decheng Capital
BlackRock
Balyasny Asset Management
GSA Capital Partners
Tybourne Capital Management
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals